Lincoln Pharmaceuticals fundamental analysis
LINCOLN
480.75
4.25 (-0.88%)Last updated on 14 Jan, 2026 | 10:39 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Lincoln Pharmaceuticals Fundamentals
P/E Ratio
12.1
P/B Ratio
1.35
Div. Yield
0.37
Sector P/E
69.86
Sector P/B
0.96
Sec. Div. Yield
0.57
Lincoln Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 12.1, compared to the sector average of 69.86. Its P/B Ratio stands at 1.35, while the sector’s is 0.96. In terms of returns, the stock offers a Dividend Yield of 0.37%, which is than the sector’s 0.57%.
Lincoln Pharmaceuticals Score Card
Price
Expensive
Growth
Average
Quality
Good
Management
Good
On its scorecard, Lincoln Pharmaceuticals reflects: Price – Expensive, Growth – Average, Quality – Good, and Management – Good. Together, these indicators provide a structured view of the company’s fundamentals.
